INO

AstraZeneca Cuts Almost All Ties to Inovio Pharma

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca PLC (NASDAQ: AZN) would be scaled back. AstraZeneca subsidiary MedImmune is ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex, Voya and More

Stocks were indicated to open higher on Tuesday as bond yields appear to be stabilizing after the yield curve inverted late last week. Investors need to consider how they want ...
Read Full Story »

5 Buy-Rated Stocks Under $5 With Massive Implied Upside Potential

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of ...
Read Full Story »

5 Sizzling Biotech Stocks Under $10 With Gigantic Upside Potential

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of ...
Read Full Story »

Inovio Pharmaceuticals Kicks Off Late-Stage HPV Clinical Trial

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares posted a solid gain on Thursday after the company announced that it was beginning its late-stage trial of its treatment for cervical dysplasia caused ...
Read Full Story »

Is Inovio Pharma’s Zika Vaccine the Next Big Thing?

Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO) saw a handy gain early on Wednesday after the company gave an update on its Zika virus study. Specifically, Inovio said that its ...
Read Full Story »

7 Speculative Biotech and Pharma Stocks That Could Still Double (or More)

As the markets roll into summer, the markets are close to all-time highs and investors are wondering how they should be positioned as the bull market is now over eight ...
Read Full Story »

Why Inovio Pharmaceuticals May Be the Next Big Thing

Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO) saw a massive gain early on Wednesday after the company announced a critical update from its HIV vaccine. Specifically, the company said that ...
Read Full Story »
mosquito

Inovio Rises on Positive Zika Vaccine Results in First Human Study

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares saw a handy gain on Wednesday after the company reported positive results from its early-stage Zika trial. Specifically, the company said that its DNA-based ...
Read Full Story »
clinical trials

Inovio Pharma Tanks on FDA Clinical Hold

Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO) slid in Monday’s session after the firm received some bad news from the U.S. Food and Drug Administration (FDA). Essentially, the agency placed a ...
Read Full Story »
thumbs up and down

Top Analyst Upgrades and Downgrades: Ford, GM, Hecla Mining, Vale, Waste Management and More

Stocks have been hitting new all-time highs, and Tuesday's opening bell was indicated to open higher. Stocks are valued at about 18 times forward earnings on the S&P 500 Index, ...
Read Full Story »
mosquito

How Inovio Pharma Is Joining the Fight Against the Zika Virus

Inovio Pharmaceuticals Inc. (NASDAQ: INO), in conjunction with GeneOne Life Science, is pioneering a new treatment for the Zika virus. In fact, early Monday morning the companies announced that they have ...
Read Full Story »
mosquito

7 Companies in the Fight to Defeat the Zika Virus

In 2016, it is the Zika virus that has the public worried about the next pandemic. Past scares have been around Ebola, E. coli, SARS, mad cow, swine flu and ...
Read Full Story »
buy button

Energy Stocks Highlight Slow Earnings Season Insider Buying: Summit Midstream, Western Refining Logistics, Monsanto and More

Regular 24/7 Wall St. readers know that earnings season typically slows the rate of insider activity in a big way. Corporations go into what is called the silent period, before, ...
Read Full Story »
biotech word cloud

Top 6 Biopharma Movers of the Past Week

Over the past week, a few biotech companies made impressive runs. These moves were the result of clinical trial results, U.S. Food and Drug Administration (FDA) decisions and more. The ...
Read Full Story »